(Q38559239)

4 September 2017

title

Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma (English)

1 reference

4 September 2017

0 references

Williams JA

1

1 reference

4 September 2017

Dillehay LE

2

1 reference

4 September 2017

Tabassi K

3

1 reference

4 September 2017

Sipos E

4

1 reference

4 September 2017

Fahlman C

5

1 reference

4 September 2017

Brem H

6

1 reference

4 September 2017

publication date

1 May 1997

1 reference

Journal of Neuro-Oncology

4 September 2017

published in

1 reference

4 September 2017

volume

32

1 reference

4 September 2017

issue

3

1 reference

4 September 2017

page(s)

181-192

1 reference

Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme

4 September 2017

cites work

1 reference

12 December 2020

A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer

1 reference

12 December 2020

Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).

1 reference

12 December 2020

A new method for determining dose rate distribution from radioimmuno-therapy using radiochromic media

1 reference

12 December 2020

Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

1 reference

12 December 2020

Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts

1 reference

12 December 2020

Chemotherapy for malignant gliomas

1 reference

12 December 2020

Iododeoxyuridine uptake and retention as a measure of tumor growth.

1 reference

12 December 2020

Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine

1 reference

12 December 2020

Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors

1 reference

12 December 2020

Comparison of intravenous and intra-arterial pyrimidine infusion as a means of radiosensitizing tumors in vivo

1 reference

12 December 2020

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

12 December 2020

Assumptions in the radiotherapy of glioblastoma

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.

1 reference

12 December 2020

Intraarterial iododeoxyuridine infusion combined with irradiation. A pilot study

1 reference

12 December 2020

Use of bremsstrahlung radiation to monitor Y-90 tumor and whole body activities during experimental radioimmunotherapy in mice

1 reference

12 December 2020

Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.

1 reference

12 December 2020

Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines

1 reference

12 December 2020

Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity

1 reference

12 December 2020

The development of polyanhydrides for drug delivery applications

1 reference

12 December 2020

Erosion kinetics of hydrolytically degradable polymers

1 reference

12 December 2020

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).

1 reference

12 December 2020

Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields.

1 reference

12 December 2020

Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation

1 reference

12 December 2020

Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics

1 reference

12 December 2020

Response of glioblastoma cell lines to low dose rate irradiation

1 reference

12 December 2020

MOLECULAR RADIOBIOLOGY OF HUMAN CELL LINES. V. COMPARATIVE RADIOSENSITIZING PROPERTIES OF 5-HALODEOXYCYTIDINES AND 5-HALODEOXYURIDINES.

1 reference

12 December 2020

Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma

1 reference

12 December 2020

Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine.

1 reference

12 December 2020

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials

1 reference

12 December 2020

Genetics of human cell lines. III. Incorporation of 5-bromo- and 5-iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity

1 reference

12 December 2020

Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme

1 reference

12 December 2020

Blood-brain barrier: a definition of normal and altered function

1 reference

12 December 2020

Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas

1 reference

12 December 2020

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

1 reference

12 December 2020

Injectable Polyanhydride Granules Provide Controlled Release of Water-Soluble Drugs with a Reduced Initial Burst

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005704913330

1 reference

Dimensions Publication ID

4 September 2017

1000797517

0 references

1 reference